Drug recall · July 23, 2025
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg recall
Why: Product Mix Up: This product is being recalled because of a complaint received that a sealed bottle of lisinopril and hydrochlorothiazide tablets 20mg/12.5 mg had a foreign tablet identified as atazanavir and ritonavir tablet 300mg/100mg.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Lisinopril and Hydrochlorothiazide Tablets USP 20mg/12.5mg, 100-count bottles, Rx only, Mfg for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, Manufactured by: Lupin Limited Nagpur-441 108, INDIA, NDC 68180-519-01
- Lots / codes
Lot #: QA01081, Exp. Date April 2027
- Quantity
- 58,968 bottles
- Company
- Lupin Pharmaceuticals Inc., Naples, FL
- Distribution
- Product was distributed nationwide within the United States.
- Initiated
- June 20, 2025 · Voluntary: Firm initiated
- Classified
- July 17, 2025
- Reported
- July 23, 2025
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Hydrochlorothiazide / lisinopril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.